Patient Based Evidence: Using patient preference research for PBAC/MSAC
The Patient Voice Initiative invites patient groups and communities to join us for this three-part webinar series on patient-based evidence. In this webinar, we’ll focus on answering your questions about patient preference studies.
- Data that makes a difference and what patient-based evidence can add (Jo Watson, PBAC Deputy Chair)
- What is patient preference research and what can it do? (Dr Simon Fifer, CaPPRe and PVI)
- How and why Myeloma Australia uses patient preference research (Steve Roach, CEO, Myeloma Australia & Nella Combe, Nurse, Myeloma Australia)
- Time for your questions
This webinar is provided for free, thanks to the following sponsorship of the Patient Voice Initiative:
Gold Sponsors: Bristol-Myers Squibb; Lilly; Sanofi
Silver Sponsors: Astra Zeneca; Biogen; Janssen; MSD; Pfizer; Medicines Australia; Shire/Takeda
Ongoing inkind support: CaPPRe; Rare Cancers Australia
And the generosity of all speakers who have given their time for free.